Michael Skinner

1.9k total citations
25 papers, 1.4k citations indexed

About

Michael Skinner is a scholar working on Pharmacology, Pharmacology and Surgery. According to data from OpenAlex, Michael Skinner has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Pharmacology and 4 papers in Surgery. Recurrent topics in Michael Skinner's work include Treatment of Major Depression (5 papers), Nausea and vomiting management (4 papers) and Poisoning and overdose treatments (3 papers). Michael Skinner is often cited by papers focused on Treatment of Major Depression (5 papers), Nausea and vomiting management (4 papers) and Poisoning and overdose treatments (3 papers). Michael Skinner collaborates with scholars based in United States, Australia and Singapore. Michael Skinner's co-authors include Terrence F. Blaschke, Alan Rubinow, Alan S. Cohen, Mary Pat Knadler, Celedon Gonzales, Shobha Reddy, R. Clark Lantz, Feng Yu Kuo, Richard Halliwell and Peter R. Gibson and has published in prestigious journals such as Circulation, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Michael Skinner

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Skinner United States 16 412 280 258 248 242 25 1.4k
Inge De Lepeleire United States 28 563 1.4× 278 1.0× 391 1.5× 368 1.5× 480 2.0× 80 2.4k
Jacqueline B. McCrea United States 26 297 0.7× 184 0.7× 299 1.2× 300 1.2× 169 0.7× 77 2.0k
Michelle I. Wilde New Zealand 26 347 0.8× 300 1.1× 162 0.6× 461 1.9× 183 0.8× 43 2.0k
John F. Gerkens Australia 23 391 0.9× 240 0.9× 157 0.6× 185 0.7× 285 1.2× 54 1.4k
John H. Cavanaugh United States 23 222 0.5× 156 0.6× 94 0.4× 201 0.8× 145 0.6× 59 1.7k
Kari Aranko Finland 20 156 0.4× 308 1.1× 154 0.6× 139 0.6× 101 0.4× 47 1.6k
William A. Wargin United States 23 408 1.0× 249 0.9× 110 0.4× 177 0.7× 89 0.4× 54 1.9k
Michael J. Fossler United States 22 153 0.4× 371 1.3× 230 0.9× 255 1.0× 135 0.6× 69 1.5k
Teijo I. Saari Finland 27 583 1.4× 125 0.4× 97 0.4× 318 1.3× 253 1.0× 63 2.0k
Walter Ziegler Switzerland 25 419 1.0× 404 1.4× 588 2.3× 469 1.9× 291 1.2× 82 2.5k

Countries citing papers authored by Michael Skinner

Since Specialization
Citations

This map shows the geographic impact of Michael Skinner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Skinner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Skinner more than expected).

Fields of papers citing papers by Michael Skinner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Skinner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Skinner. The network helps show where Michael Skinner may publish in the future.

Co-authorship network of co-authors of Michael Skinner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Skinner. A scholar is included among the top collaborators of Michael Skinner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Skinner. Michael Skinner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mason, Barbara J., Amanda J. Roberts, Giordano de Guglielmo, et al.. (2024). A reverse translational study of PPAR-α agonist efficacy in human and rodent models relevant to alcohol use disorder. Neurobiology of Stress. 29. 100604–100604. 5 indexed citations
2.
Lobo, Evelyn D., Michael Heathman, Shobha Reddy, et al.. (2010). Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of Duloxetine. Clinical Pharmacokinetics. 49(5). 311–321. 28 indexed citations
3.
Suri, Ajit, Shobha Reddy, Celedon Gonzales, et al.. (2005). Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 43(2). 78–84. 39 indexed citations
4.
Siemers, Eric, Michael Skinner, Robert A. Dean, et al.. (2005). Safety, Tolerability, and Changes in Amyloid β Concentrations After Administration of a γ-Secretase Inhibitor in Volunteers. Clinical Neuropharmacology. 28(3). 126–132. 171 indexed citations
5.
Schwartz, Garry, Christopher B. Jones, Mitchell Garrison, et al.. (2004). A phase I and pharmacokinetic study of the nonpolyglutamatable thymidylate synthase inhibitor ZD9331 plus docetaxel in patients with advanced solid malignancies. Investigational New Drugs. 22(4). 437–448. 2 indexed citations
6.
Pan, Alan X., et al.. (2004). Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers. British Journal of Clinical Pharmacology. 57(5). 652–656. 23 indexed citations
7.
Lantz, R. Clark, et al.. (2003). METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS. Drug Metabolism and Disposition. 31(9). 1142–1150. 173 indexed citations
8.
Skinner, Michael, Andrej Skerjanec, Mary Seger, et al.. (2003). Effect of age on the pharmacokinetics of duloxetine in women. British Journal of Clinical Pharmacology. 57(1). 54–61. 54 indexed citations
9.
Halliwell, Richard, et al.. (2002). Thoracic Epidural Anesthesia for Cardiac Surgery: The Effects on Tracheal Intubation Time and Length of Hospital Stay. Anesthesia & Analgesia. 94(2). 275–282. 97 indexed citations
10.
Großmann, M. & Michael Skinner. (1996). A simple computer based system to analyze Morris water maze trials on-line. Journal of Neuroscience Methods. 70(2). 171–175. 14 indexed citations
11.
Skinner, Michael, Dun-Xian Tan, M. Großmann, Michael T. Pyne, & Roderick K. Mahurin. (1996). Effects of Captopril and Propranolol on Cognitive Function and Cerebral Blood Flow in Aged Hypertensive Rats. The Journals of Gerontology Series A. 51A(6). B454–B460. 15 indexed citations
12.
Skinner, Michael & Terrence F. Blaschke. (1995). Clinical Pharmacokinetics of Rifabutin. Clinical Pharmacokinetics. 28(2). 115–125. 57 indexed citations
13.
Skinner, Michael, et al.. (1993). Effects of antihypertensive drugs atenolol and nifedipine on sexual function in older men: A placebo-controlled, crossover study. Archives of Sexual Behavior. 22(2). 99–109. 15 indexed citations
14.
Skinner, Michael, et al.. (1992). Atenolol Compared with Nifedipine: Effect on Cognitive Function and Mood in Elderly Hypertensive Patients. Annals of Internal Medicine. 116(8). 615–623. 41 indexed citations
15.
Skinner, Michael & David A. Thompson. (1992). Pharmacologic Considerations in the Treatment of Substance Abuse. Southern Medical Journal. 85(12). 1207–1219. 3 indexed citations
16.
Skinner, Michael. (1990). Adverse Reactions and Interactions with Theophylline. Drug Safety. 5(4). 275–285. 19 indexed citations
17.
Skinner, Michael, Leslie Lenert, & Terrence F. Blaschke. (1989). Theophylline toxicity subsequent to ranitidine administration: A possible drug-drug interaction. The American Journal of Medicine. 86(1). 129–132. 17 indexed citations
18.
Skinner, Michael, John W. Torseth, Gulshan Bhatia, et al.. (1989). Pharmacokinetics of rifabutin. Antimicrobial Agents and Chemotherapy. 33(8). 1237–1241. 68 indexed citations
19.
Skinner, Michael, et al.. (1987). Sulindac inhibits bumetanide-induced sodium and water excretion. Clinical Pharmacology & Therapeutics. 42(5). 542–546. 5 indexed citations
20.
Rubinow, Alan, Michael Skinner, & Alan S. Cohen. (1981). Digoxin sensitivity in amyloid cardiomyopathy.. Circulation. 63(6). 1285–1288. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inge De Lepeleire Breakdown of academic impact, for papers by Jacqueline B. McCrea Breakdown of academic impact, for papers by Michelle I. Wilde Breakdown of academic impact, for papers by John F. Gerkens Breakdown of academic impact, for papers by John H. Cavanaugh Breakdown of academic impact, for papers by Kari Aranko Breakdown of academic impact, for papers by William A. Wargin Breakdown of academic impact, for papers by Michael J. Fossler Breakdown of academic impact, for papers by Teijo I. Saari Breakdown of academic impact, for papers by Walter Ziegler
Rankless by CCL
2026